MJardin Receives Cultivation, Processing License For Warman Facility

MJardin Group Inc MJAR MJARF said Monday that it received a Health Canada cultivation and processing license for Warman, a 120,000-square-foot facility in Winnipeg, Manitoba and the largest in the company's portfolio. 

The construction of the building is finished and cultivation will begin promptly, the company said. 

“This is a great milestone for our flagship facility in Winnipeg and a great day for the team,” CEO Pat Witcher said in a statement. 

“The timing of this achievement keeps us on schedule to reach full capacity in Manitoba by the end of 2020. It also allows us to focus more of our production on extraction at this facility and take full advantage of that high-value market.”

A hybrid facility with both indoor and greenhouse production capability is planned, with certified extraction, processing and packaging capabilities.

Phase 2 of construction is expected to be completed in the fourth quarter of 2020, helping the facility reach a production capacity of about 4,500 kg of dried flower and 800 liters of bulk oil, according to MJardin

The license announced Monday is MJardin’s third cultivation and processing permit in Canada.

The stock was down 3.85% at 17 cents at the time of publication. 

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Cannabis is evolving – don’t get left behind!

Curious about what’s next for the industry and how to leverage California’s unique market?

Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!

Get your tickets now to secure your spot and avoid last-minute price hikes.